Market Cap
$156.47 M
+$2.20 M+1.43%
Fri, 07 Feb 2025 00:54:37 GMT
Summary
- As of February 7, 2025, LCTX market capitalization is $156.47 million, with a rise of +$2.20 million (+1.43%) during the most recent trading day.
- Over the past year, LCTX market cap has dropped by -$52.74 million (-25.21%).
- LCTX market cap is now -67.83% below its all-time high of $486.42 million.
Performance
LCTX Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Market Cap Formula
Market Cap = Price ✕ Shares Outstanding
LCTX Market Cap Trends
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | Enterprise valueEnterprise value |
|---|---|---|---|---|
| todaytoday | +1.4% | +1.4% | +16.7% | +1.7% |
| 1 m1 month | +24.7% | +24.7% | - | +30.9% |
| 3 m3 months | -10.9% | -23.7% | - | -12.7% |
| 6 m6 months | -9.9% | -22.8% | - | -10.6% |
| ytdytd | +36.8% | +36.8% | - | +47.1% |
| 1 y1 year | -25.2% | -36.0% | +25.9% | -25.6% |
| 5 y5 years | -20.3% | -45.8% | +47.1% | -31.5% |
LCTX Market Cap Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | $124 M | +26.1% | |
| 3 m | 3-month | $183 M | -14.6% | $110 M | +42.0% |
| 6 m | 6-month | $183 M | -14.6% | $110 M | +42.0% |
| 1 y | 1-year | $281 M | -44.4% | $110 M | +42.0% |
| 3 y | 3-year | $300 M | -47.9% | $110 M | +42.0% |
| 5 y | 5-year | $486 M | -67.8% | $90 M | +74.1% |
| alltime | all time | $486 M | -67.8% | $3.57 M | +4277.7% |
Lineage Cell Therapeutics Market Cap History
| Date | Value |
|---|---|
| 2025 | $156.47 M(+36.8%) |
| 2024 | $114.40 M(-40.0%) |
| 2023 | $190.74 M(-4.2%) |
| 2022 | $199.01 M(-52.1%) |
| 2021 | $415.22 M(+54.1%) |
| 2020 | $269.45 M(+102.1%) |
| 2019 | $133.33 M(+15.2%) |
| 2018 | $115.69 M(-57.6%) |
| 2017 | $272.76 M(-26.5%) |
| 2016 | $371.02 M(+0.1%) |
| 2015 | $370.73 M(+27.1%) |
| 2014 | $291.79 M(+42.9%) |
| 2013 | $204.17 M(+31.7%) |
| 2012 | $155.06 M(-45.6%) |
| 2011 | $284.90 M(-23.6%) |
| 2010 | $373.00 M(+161.9%) |
| 2009 | $142.41 M(+238.1%) |
| Date | Value |
|---|---|
| 2008 | $42.12 M(+345.8%) |
| 2007 | $9.45 M(+55.0%) |
| 2006 | $6.10 M(-12.0%) |
| 2005 | $6.93 M(-74.3%) |
| 2004 | $26.90 M(+42.7%) |
| 2003 | $18.84 M(-9.9%) |
| 2002 | $20.91 M(-60.9%) |
| 2001 | $53.49 M(-37.6%) |
| 2000 | $85.70 M(-11.3%) |
| 1999 | $96.66 M(-44.6%) |
| 1998 | $174.32 M(-6.8%) |
| 1997 | $187.06 M(+109.2%) |
| 1996 | $89.41 M(+936.8%) |
| 1995 | $8.62 M(+63.8%) |
| 1994 | $5.26 M(-60.9%) |
| 1993 | $13.47 M(-19.2%) |
| 1992 | $16.68 M |
FAQ
- What is Lineage Cell Therapeutics market capitalization?
- What is the all time high market cap for Lineage Cell Therapeutics?
- What is LCTX market capitalization year-to-date change?
- What is Lineage Cell Therapeutics market cap year-on-year change?
What is Lineage Cell Therapeutics market capitalization?
The current market cap of LCTX is $156.47 M
What is the all time high market cap for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high market capitalization is $486.42 M
What is LCTX market capitalization year-to-date change?
Lineage Cell Therapeutics market capitalization has changed by +$42.08 M (+36.78%) since the beginning of the year
What is Lineage Cell Therapeutics market cap year-on-year change?
Over the past year, LCTX market capitalization has changed by -$52.74 M (-25.21%)